Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-18CASI3Form 4 Filing for CASI Pharmaceuticals, Inc.MEDIUM
This filing details the ownership of CASI Pharmaceuticals, Inc. (CASIF) ordinary shares by Wei-Wu He. It includes direct holdings of ordinary shares and options to buy, as well as indirect holdings through various entities such as Emerging Technology Partners, LLC, ETP Global Fund. L.P., ETP BioHealth III Fund, L.P., H...
Nano CapBiotechnology
2026-03-18CASI3Initial Statement of Beneficial OwnershipMEDIUM
This filing details the initial statement of beneficial ownership for James Huang, a director at CASI Pharmaceuticals, Inc. As of March 18, 2026, Huang directly holds 10000 stock options exercisable at $1.69, expiring on October 1, 2035, and another 10000 stock options exercisable at $2.69, expiring on May 1, 2033. Add...
Nano CapBiotechnology